Details for Patent: 7,517,334

Which drugs does patent 7,517,334 protect, and when does it expire?

Patent 7,517,334 protects FORTEO and is included in one NDA.

This patent has thirty-seven patent family members in twenty-five countries.

Summary for Patent: 7,517,334

Title:	Medication dispensing apparatus with spring-driven locking feature enabled by administration of final dose
Abstract:	A medication dispensing apparatus with a spring-driven locking feature includes a drive member movable in a distal direction within a housing, and a fluid container with a piston that is advanceable by the drive member (60) when such drive member is moved distally by a driving means. The apparatus includes a latching element (180) having a skid (190) that is slidable along a surface of the drive member as the drive member passes distally during advancement. The drive member is arranged with the skid so as to maintain a latching lip of the latching element against a spring force in a first position free of the driving means during dose preparing and injecting prior to a final dose administration. The skid-engaging surface shifts distally of the skid such that the skid passes beyond a proximal end of that surface upon administration of a final dose, whereby the latching lip is urged by the spring force from the first position to a second position to physically lock the driving means to prevent further dose preparing and injecting.
Inventor(s):	Jacobs; Alexander Thomas (Cambridge, MA), Judson; Jared Alden (Topsfield, MA), Row; Gordon Davidson (Groton, MA)
Assignee:	Eli Lilly and Company (Indianapolis, IN)
Application Number:	10/598,987
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 7,517,334
Patent Claim Types: see list of patent claims	Use; Device;

Recent additions to Drugs Protected by US Patent 7,517,334

These patents are from the daily update and have not yet been integrated into the regular database

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Type	RLD	Patent No.	Product	Substance	Delist Req.	Patent Expiration	Usecode	Patented / Exclusive Use
Lilly	FORTEO	teriparatide	SOLUTION	021318	Jun 25, 2008	RX	Yes		Y
Lilly	FORTEO	teriparatide	SOLUTION	021318	Nov 26, 2002	DISCN	No		Y

Drugs Protected by US Patent 7,517,334

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Lilly	FORTEO	teriparatide	SOLUTION;SUBCUTANEOUS	021318-002	Jun 25, 2008	AP	RX	Yes	Yes			Y
Lilly	FORTEO	teriparatide	SOLUTION;SUBCUTANEOUS	021318-001	Nov 26, 2002		DISCN	No	No			Y

Foreign Priority and PCT Information for Patent: 7,517,334

PCT Information
PCT Filed	March 25, 2005	PCT Application Number:	PCT/US2005/010206
PCT Publication Date:	October 20, 2005	PCT Publication Number:	WO2005/097233

International Family Members for US Patent 7,517,334

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Austria	E526052
Australia	2005231731
Brazil	PI0509269
Canada	2557897
China	100581607